(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 36.27%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,382.57%.
Endra Life Sciences's earnings in 2026 is -$7,302,513.On average, 3 Wall Street analysts forecast NDRA's earnings for 2026 to be -$4,585,994, with the lowest NDRA earnings forecast at -$4,406,151, and the highest NDRA earnings forecast at -$4,720,876.
In 2027, NDRA is forecast to generate -$3,938,255 in earnings, with the lowest earnings forecast at -$3,783,813 and the highest earnings forecast at -$4,054,086.